There is a version of the principal investigator role that exists only on paper. The name appears on the 1572, the CV sits in the regulatory binder, the signature shows up where signatures are required, and the actual conduct of the study happens several rooms away without that person in it.

That arrangement is common enough that people stop noticing it. It is also a misreading of what the role is, and the misreading tends to surface at the worst possible moment.

From Lakewood Ranch, Florida, Justin Coffeen works on three kinds of trial and carries IHI certification in Good Clinical Practice. He has watched the investigator relationship work well and watched it work badly, and the difference is rarely about the physician’s clinical ability.

Delegation transfers the task, not the responsibility

An investigator can delegate almost every study activity. Coordinators consent participants, perform assessments, enter data, and manage the regulatory file. That delegation is legitimate and it is how sites function.

What delegation does not do is move accountability. The investigator remains responsible for the conduct of the study at that site, including work performed by people the investigator personally trained and authorized. Coffeen puts it plainly. The delegation log distributes the work and concentrates the responsibility, which is the opposite of how people tend to read it.

This is why the delegation log deserves more attention than it usually gets. It is not a staffing roster. It is the document in which an investigator states, in writing, which specific people they are vouching for and for which specific activities.

Medical judgment cannot be handed down the log

Some decisions are not delegable regardless of how capable the coordinator is. Determining eligibility against clinical criteria, assessing causality for an adverse event, and deciding whether a participant should continue all require the investigator.

Sites under time pressure sometimes let these drift, with a coordinator drafting a causality assessment for later signature or making an eligibility call the investigator ratifies without review. Coffeen’s clinical background makes him unusually alert to this, because he knows what it means to be the person whose judgment a record reflects. A signature applied to somebody else’s assessment is not the same document as an assessment the signer actually made.

The pressure that produces this drift is almost never malicious. It is a busy physician, a capable coordinator, and a queue of decisions that all need to happen today. Recognizing the pattern as a predictable consequence of workload, rather than a character failing, is what makes it fixable.

Oversight has to leave evidence

An investigator who reviews everything carefully but leaves no trace of having done so is, from a regulatory standpoint, difficult to distinguish from one who reviewed nothing.

This frustrates good physicians, and it is still true. Dated signatures on source records, documented attendance at study meetings, timely review of safety information, and a record of the investigator’s involvement in deviation decisions are what oversight looks like from the outside. Coffeen builds those touchpoints into workflow rather than requesting them retroactively, because a signature collected three weeks later documents a signature, not an oversight.

Coffeen’s preference is for review to happen at natural points in the workflow rather than in a separate pass. An investigator who signs source records as visits close is documenting oversight as it occurs. One who signs a stack at month end is documenting something else.

Availability is a protocol requirement in practice

The most useful thing an investigator provides a coordinator is reachability. A participant reports something ambiguous during a visit, and the question of whether it is reportable, expected, or clinically significant needs an answer that day.

Coffeen keeps that path short and agreed in advance. When the investigator is unavailable, someone qualified is covering, and the coordinator knows who before the situation arises. Studies do not fail because an investigator was busy. They accumulate problems because nobody defined what happens during the hours the investigator is not there.

The role is not ceremonial. Everything a site produces carries an investigator’s name on it, and the sites that treat that as a working relationship rather than a signing arrangement generate data that holds up. The ones that do not are usually fine right up until someone looks closely.